New Report Periodontal Disease – Drug Pipeline Analysis and Market Forecasts to 2016 added by WorldMarketStudy
for the Periodontal Disease Market
2.4.1 Drivers for the Periodontal Disease Market
2.4.2 Barriers for the Periodontal Disease Market
2.5 Opportunity and Unmet Need
2.6 Key Takeaway
3 Global Periodontal Disease Market: Competitive Assessment
3.1 Overview
3.2 Strategic Competitor Assessment
3.3 Product Profile for the Major Marketed Products in the Periodontal Disease Market
3.3.1 Periostat (Doxycycline Hyclate)
3.3.2 Arestin (minocycline hydrochloride microspheres)
3.3.3 Periochip (chlorhexidine gluconate)
3.3.4 Atridox (doxycycline hyclate 10%)
3.4 Key Takeaway
4 Global Periodontal Disease Market: Pipeline Assessment
4.1 Overview
4.2 Strategic Pipeline Assessment
4.3 Periodontal Disease Market – Promising Drugs under Clinical Development
4.4 Molecule Profile for Promising Drugs under Clinical Development
4.4.1 Minocycline HCl
4.4.2 Trafermin (bFGF: Basic fibroblast growth factor)
4.5 Periodontal Disease Market – Clinical Pipeline by Mechanism of Action
4.5.1 Periodontal Disease – Phase III Clinical Pipeline
4.5.2 Periodontal Disease – Phase II Clinical Pipeline
4.5.3 Periodontal Disease – Phase I Clinical Pipeline
4.5.4 Periodontal Disease- Preclinical Pipeline
4.6 Key Takeaway
5 Global Periodontal Disease Market: Implications for Future Market Competition
6 Global Periodontal Disease Syndrome Market: Future Players
6.1 Introduction
6.2 Fibrocell Sciences, Inc
6.2.1 Company Overview
6.2.2 Business description
6.3 Orapharma
6.3.1 Company Overview
6.3.2 Business Description
6.4 Tolmar Inc
6.4.1 Company Overview
6.4.2 Business Description
6.5 Kaken Pharmaceutical
6.5.1 Overview
6.5.2 Business Description
6.6 Eli Lilly & Company
6.6.1 Company Overview
6.6.2 Business Description
7 Periodontal disease Market: Appendix
7.1 Definitions
7.2 Acronyms
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasting
7.3.4 Primary Research
7.3.5 Expert Panels
7.4 Contact Us
7.5 Disclaimer
7.6 Sources
1.1 List of Tables
Table 1: Various Types of Medications Employed in Treating the Periodontal Disease 6
Table 2: Periodontal Disease, Global, Historical Revenue ($m), 2001-2009 7
Table 3: Periodontal Disease, Global, Forecasted Reveune ($m), 2009-2016 8
Table 4: Major Marketed Products Comparison in Periodontal Disease Market, 2010 16
Table 5: Periodontal Disease – Most Promising Drugs Under Clinical Development, 2010 20
Table 6: Periodontal Disease – Phase III Clinical Pipeline, 2010 22
Table 7 Periodontal Disease- Phase II Clinical Pipeline, 2010 22
Table 8 Periodontal Disease – Phase I Clinical Pipeline, 2010 23
Table 9: Periodontal Disease – Preclinical Pipeline, 2010 23
Table 10: Fibrocell Sciences, Inc – Periodontal disease Pipeline Product Portfolio, 2010 26
Table 11: Genzyme Corporation – Periodontal Disease Pipeline Product Portfolio, 2010 26
Table 12: Tolmar, Inc – Periodontal Disease Pipeline Product Portfolio, 2010 27
Table 13: Kaken Pharmaceutical – Periodontal Pipeline Product Portfolio, 2010 28
Table 14: Eli Lilly – Periodontal Disease Pipeline Product Portfolio, 2010 29
1.2 List of Figures
Figure 1: Periodontal Disease, Global, Historical Revenue ($m), 2001-2009
Figure 2: Periodontal Disease, Global, Forecasted Revenue ($m), 2009-2016
Figure 3: Opportunity and Unmet Need in the Periodontal Disease Market, 2010
Figure 4: Strategic Competitor Assessment, 2010
Figure 5: Pipeline Products by Phase of Development, 2009
Figure 6: Technology Trends Analytics Frame Work, 2010
Figure 7: Technology Trends Analytics Frame Work – Description, 2010
Figure 8: Periodontal Disease Market – Clinical Pipeline by Mechanism of Action, 2010
Figure 9: Periodontal Disease Market – Clinical Pipeline by Phase of Development, 2010
Figure 10: Implications for Future Market Competition in the Periodontal Disease Market, 2010
Figure 11: Periodontal Disease Market – Clinical Pipeline by Company, 2010
Figure 12: GlobalData Methodology, 2010
Figure 13: GlobalData Market Forecasting Model, 2010